Drawing for PRIMAL THERAPEUTICS

USPTO serial 87276399

PRIMAL THERAPEUTICS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
PRATER, JILL I
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PRIMAL THERAPEUTICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Nutraceuticals for use as a regulated drug; additives to pharmaceutical preparations; additives to medical devices; pharmaceutical preparations for medical devices; pharmaceutical preparations; pharmaceutical preparations for the treatment of skin and mucosal infections and allergies in humans; nutritional and dietary food supplements; topical gel for medical treatment of traumatic and iatrogenic wounds, incisions, excoriations, burns and other conditions related to the loss of epidermis and/or dermis; preparations for destroying vermin, parasiticides, fungicides; allergy capsules, allergy medication, allergy tablets, diagnostic test patch for application to the skin for determining allergies, non-medicated topical gel for the prevention and treatment of allergies; drug delivery agents in the form of powders, tablets and capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; sanitizing preparations for use in institutional and industrial areas; all the aforementioned made with non-toxic ingredientsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jan 22, 2018MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 22, 2018ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 21, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 25, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 25, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 5, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 14, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 13, 2017DOCKASSIGNED TO EXAMINER—
Jan 31, 2017TAEATEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED—
Jan 31, 2017PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Jan 31, 2017TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 31, 2017WOAGWITHDRAWAL OF ATTORNEY GRANTED—
Jan 31, 2017WOARTEAS WITHDRAWAL OF ATTORNEY RECEIVED—
Jan 3, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 24, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance